Curcumin and its water-soluble conjugates lower the neutrophil-to-lymphocyte ratio, addressing a key prognosis marker across inflammatory and viral diseases.
A dual-component paeoniflorin and isoliquiritigenin formulation targets pulmonary fibrosis while reducing inflammation, collagen deposition, and cost.
Marine phospholipids form sub-500 nm emulsions that improve solubility, permeability, and GI absorption of poorly bioavailable therapeutics.
A lecithin-mediated SNEDDS combines oils, PEG 400, and nanoliposomes to stabilize quercetin and improve bioavailability.
Water-dispersible nutraceutical powders combine surfactants, oils, and release polymers to raise bioavailability while reducing dose size and frequency.
Weekly IV liposomal curcumin cycles with rest periods improve anti-proliferative activity while limiting systemic toxicity.